Zyvox and Amitiza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zyvox (linezolid) and Amitiza (lubiprostone). Common drug interactions include rash among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Zyvox and Amitiza. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Zyvox?

Zyvox has active ingredients of linezolid. It is often used in mrsa infection. eHealthMe is studying from 9,399 Zyvox users. Check the latest studies of Zyvox.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

31 people who take Zyvox and Amitiza together, and have interactions are studied.

Zyvox and Amitiza drug interactions.

What are the common drug interactions of Zyvox and Amitiza, by gender? *:

female:

  1. Rash
  2. Anxiety
  3. Diarrhoea
  4. Adverse drug reaction
  5. Dizziness
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Insomnia (sleeplessness)
  8. Nausea (feeling of having an urge to vomit)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Cholecystitis acute (rapid infection of gallbladder)

male:

  1. Chronic kidney disease
  2. Decreased appetite
  3. Burning sensation
  4. Emotional distress
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Interstitial lung disease
  7. Irritability
  8. Joint injury
  9. Limb injury
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Zyvox and Amitiza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood alkaline phosphatase increased
  4. Bone density decreased
  5. Burning sensation
  6. Chronic kidney disease
  7. Emotional distress
  8. Irritability
  9. Joint injury
  10. Limb injury

40-49:

  1. Dental caries
  2. Dystonia (abnormal muscle tone)
  3. Facial bones fracture (bone fracture of face)
  4. Fall
  5. Pneumonia
  6. Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Cholecystitis acute (rapid infection of gallbladder)
  2. Depression
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Decreased appetite
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Diarrhoea
  9. Inappropriate antidiuretic hormone secretion
  10. Interstitial lung disease

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 19.35%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.13%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 12.90%
  4. Infection: 4 people, 12.90%
  5. High Blood Pressure: 4 people, 12.90%
  6. Stress And Anxiety: 3 people, 9.68%
  7. Irritable Bowel Syndrome: 2 people, 6.45%
  8. Infectious Pleural Effusion (infectious fluid in the lung): 2 people, 6.45%
  9. Multiple Allergies (allergy to multiple agents): 2 people, 6.45%
  10. Indigestion: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Zyvox and Amitiza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zyvox and Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zyvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zyvox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitiza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on linezolid and lubiprostone (the active ingredients of Zyvox and Amitiza, respectively), and Zyvox and Amitiza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: